These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 2582067)
1. Immunoregulation during acute infection with Epstein-Barr virus: dynamics of interferon and 2',5'-oligoadenylate synthetase activity. Brewster FE; Byron KS; Sullivan JL J Infect Dis; 1985 Jun; 151(6):1109-15. PubMed ID: 2582067 [TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-infected B lymphoblastoid cell lines: dynamics of interferon and 2'5'-oligoadenylate synthetase activity. Brewster FE; Sullivan JL Antiviral Res; 1983 Sep; 3(3):195-209. PubMed ID: 6197029 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of Epstein-Barr virus infection in vitro by recombinant human interferons alpha and gamma. Kure S; Tada K; Wada J; Yoshie O Virus Res; 1986 Sep; 5(4):377-90. PubMed ID: 3022498 [TBL] [Abstract][Full Text] [Related]
4. Defective generation of killer cells against spontaneously Epstein-Barr virus (EBV)-transformed autologous B cells in a fatal EBV infection. Yanagisawa M; Kato M; Ikeno K; Kobayashi T; Miyagawa Y; Komiyama A; Akabane T Clin Exp Immunol; 1987 May; 68(2):251-8. PubMed ID: 2820633 [TBL] [Abstract][Full Text] [Related]
5. Immunological effects of treatment with sequential administration of recombinant interferon gamma and alpha in patients with metastatic renal cell carcinoma during a phase I trial. Ernstoff MS; Gooding W; Nair S; Bahnson RR; Miketic LM; Banner B; Day R; Whiteside T; Titus-Ernstoff L; Kirkwood JM Cancer Res; 1992 Feb; 52(4):851-6. PubMed ID: 1737346 [TBL] [Abstract][Full Text] [Related]
6. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis). Tosato G; Straus S; Henle W; Pike SE; Blaese RM J Immunol; 1985 May; 134(5):3082-8. PubMed ID: 2984282 [TBL] [Abstract][Full Text] [Related]
7. Virologic, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosis. Svedmyr E; Ernberg I; Seeley J; Weiland O; Masucci G; Tsukuda K; Szigeti R; Masucci MG; Blomogren H; Berthold W Clin Immunol Immunopathol; 1984 Mar; 30(3):437-50. PubMed ID: 6199144 [TBL] [Abstract][Full Text] [Related]
8. Regulation of Epstein-Barr virus infection by recombinant interferons. Selected sensitivity to interferon-gamma. Lotz M; Tsoukas CD; Fong S; Carson DA; Vaughan JH Eur J Immunol; 1985 May; 15(5):520-5. PubMed ID: 2581792 [TBL] [Abstract][Full Text] [Related]
9. The effect of tinidazole on primary EBV infection and immunocompetence. Marklund G; Ernberg I; Britton S; Lundberg C Scand J Infect Dis; 1984; 16(1):17-23. PubMed ID: 6320359 [TBL] [Abstract][Full Text] [Related]
10. Suppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosis. Wang F; Blaese RM; Zoon KC; Tosato G J Clin Invest; 1987 Jan; 79(1):7-14. PubMed ID: 3025263 [TBL] [Abstract][Full Text] [Related]
11. Release of lymphokines after Epstein Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans. Lotz M; Tsoukas CD; Fong S; Dinarello CA; Carson DA; Vaughan JH J Immunol; 1986 May; 136(10):3636-42. PubMed ID: 3009608 [TBL] [Abstract][Full Text] [Related]
12. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis. Strang G; Rickinson AB Eur J Immunol; 1987 Jul; 17(7):1007-13. PubMed ID: 2440688 [TBL] [Abstract][Full Text] [Related]
14. Epstein Barr virus selective T cells in infectious mononucleosis are not restricted to HLA-A and B antigens. Seeley J; Svedmyr E; Weiland O; Klein G; Moller E; Eriksson E; Andersson K; van der Waal L J Immunol; 1981 Jul; 127(1):293-300. PubMed ID: 6263974 [No Abstract] [Full Text] [Related]
15. T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis. Klein E; Ernberg I; Masucci MG; Szigeti R; Wu YT; Masucci G; Svedmyr E Cancer Res; 1981 Nov; 41(11 Pt 1):4210-5. PubMed ID: 6272964 [TBL] [Abstract][Full Text] [Related]
16. In vivo Epstein Barr virus-induced augmentation of natural killer cell activity in the Chédiak-Higashi syndrome. Katz P; Zaytoun AM; Lee JH; Fauci AS J Immunol; 1984 Feb; 132(2):571-3. PubMed ID: 6197464 [No Abstract] [Full Text] [Related]
18. The host defense system in the human newborn: the role of interferon and the natural killer cell. Read SE; Williams BR Clin Invest Med; 1984; 7(4):259-62. PubMed ID: 6085299 [TBL] [Abstract][Full Text] [Related]
19. Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis. Silins SL; Cross SM; Elliott SL; Pye SJ; Burrows SR; Burrows JM; Moss DJ; Argaet VP; Misko IS J Exp Med; 1996 Nov; 184(5):1815-24. PubMed ID: 8920869 [TBL] [Abstract][Full Text] [Related]
20. Cell-mediated immunity to Epstein-Barr-virus-transformed lymphoblastoid cells in acute infectious mononucleosis. Royston I; Sullivan JL; Periman PO; Perlin E N Engl J Med; 1975 Dec; 293(23):1159-63. PubMed ID: 171568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]